Patent details

Basic Information

Publication number:

EP2331121

PCT Application Number:

PCT/EP/2009/052689

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097791214

PCT Publication Number:

WO/2010/025964

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

VACCINE COMPRISING PROTEIN NMBO964 FROM MEISSERIA MENINGITIDIS

French Title of Invention:

VACCIN COMPRENANT LA PROTÉINE NMBO964 DE MEISSERIA MENINGITIDIS

German Title of Invention:

PROTEIN NMBO964 VON MEISSERIA MENINGITIDIS UMFASSENDER IMPFSTOFF

SPC Number:

Dates

Filing date:

06/03/2009

Grant date:

08/05/2013

EP Publication Date:

08/05/2013

PCT Publication Date:

11/03/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/06/2011

EP B1 Publication Date:

08/05/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/03/2014

Expiration date:

06/03/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/03/2009

 

 

Name:

GlaxoSmithKline Biologicals S.A.

Address:

rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Name:

University of Utrecht

Address:

Department of Molecular & Cell Biology and Institute of Bio, 3548 CH Utrecht, Netherlands (NL)

Inventor

1

Name:

STORK Michiel

Address:

Netherlands (NL)

2

Name:

BOS Martine Petronella

Address:

Netherlands (NL)

3

Name:

TOMMASSEN Johannes Petrus Maria

Address:

Netherlands (NL)

4

Name:

POOLMAN Jan

Address:

Belgium (BE)

5

Name:

WEYNANTS Vincent

Address:

Belgium (BE)

Priority

Priority Number:

0816447

Priority Date:

08/09/2008

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 39/095;

Filing date	Document type	Number of pages